Efficacy of benzbromarone in hyperuricemic patients associated with chronic kidney disease

Nucleosides, Nucleotides and Nucleic Acids

Volumn 30, Issue 12, 2011, Pages 1035-1038

  Fujimori, Shin ^a   Ooyama, K ^b   Ooyama, H ^b   Moromizato, H ^b  

^a TEIKYO UNIVERSITY   (Japan)

^b Ryogoku East Gate Clinic   (Japan)

Author keywords

Benzbromarone; Chronic kidney disease; Hyperuricemia

Indexed keywords

BENZBROMARONE; URIC ACID;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERURICEMIA; KIDNEY DYSFUNCTION; MALE; MONOTHERAPY; TREATMENT OUTCOME; URIC ACID BLOOD LEVEL;

BENZBROMARONE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERURICEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; TREATMENT OUTCOME; URIC ACID; URICOSURIC AGENTS;

EID: 84855870024     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770.2011.622732     Document Type: Article

References (4)

1. Japanese Society of Gout and Nucleic Acid Metabolism. Guidelines for the Management of Hyperuricemia and Gout (in Japanese), 2nd ed., 2010.
2. Dalbeth, N.; Kumar, S.; Stamp, L.; Gow, P. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. J. Rheumatol. 2006, 33, 1646-1650. (Pubitemid 44168841)
3. Uchida, S. Clinical efficacy of benzbromarone on hyperuricemia associated with chronic kidney disease (CKD). Igaku-to-Yakugaku 2007, 57, 879-882 (in Japanese).
4. Schlesinger, N. Management of acute and chronic gouty arthritis. Drugs 2004, 64, 2399-2416.